A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects

A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4... Eur J Clin Pharmacol (2017) 73:1121–1128 DOI 10.1007/s00228-017-2282-7 PHARMACOKINETICS AND DISPOSITION A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects 1 1 2 1 Pierre-Eric Juif & Margaux Boehler & Yves Donazzolo & Shirin Bruderer & Jasper Dingemanse Received: 28 April 2017 /Accepted: 7 June 2017 /Published online: 21 June 2017 Springer-Verlag GmbH Germany 2017 Abstract treatment B compared to A for both midazolam (16%) and Purpose In vitro data showed that selexipag and its active 1-hydroxymidazolam (20%). Exposure (area under the curve) metabolite (ACT-333679) have an inductive effect on to midazolam and 1-hydroxymidazolam was similar between CYP3A4, CYP2B6, and CYP2C9 at concentrations approxi- treatments, and the 90% confidence intervals of geometric mately 100-fold higher than the maximum plasma concentra- mean ratios were within the bioequivalence interval. tion (C ) measured under steady-state conditions. In order Treatment with midazolam, selexipag, and the combination max to confirm in vivo the lack of induction at the enterocyte level, was safe and well tolerated. we assessed the effect of selexipag on midazolam, a substrate Conclusion Exposure to midazolam and 1-hydroxymidazolam of hepatic and intestinal CYP3A4. was not affected by treatment with selexipag. Methods This study http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Pharmacology Springer Journals

A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects

Loading next page...
 
/lp/springer_journal/a-pharmacokinetic-drug-drug-interaction-study-between-selexipag-and-nhiOFsPfQs
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Biomedicine; Pharmacology/Toxicology
ISSN
0031-6970
eISSN
1432-1041
D.O.I.
10.1007/s00228-017-2282-7
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial